NeurAxis, Inc. (NRXS)
NYSEAMERICAN: NRXS · Real-Time Price · USD
5.75
-0.28 (-4.64%)
Nov 12, 2026, 4:00 PM EST - Market closed
NeurAxis Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6.53 | 3.57 | 2.69 | 2.46 | 2.68 | 2.72 | |
Revenue Growth | 94.29% | 32.89% | 9.18% | -8.37% | -1.34% | 40.98% |
Cost of Revenue | 0.9 | 0.56 | 0.36 | 0.3 | 0.3 | 0.47 |
Gross Profit | 5.63 | 3.01 | 2.32 | 2.16 | 2.39 | 2.25 |
Selling, General & Admin | 16.37 | 9.71 | 9.05 | 8.65 | 5.53 | 5.02 |
Research & Development | 0.79 | 0.49 | 0.43 | 0.17 | 0.23 | 0.2 |
Operating Expenses | 17.16 | 10.21 | 9.48 | 8.82 | 5.76 | 5.22 |
Operating Income | -11.53 | -7.2 | -7.16 | -6.66 | -3.37 | -2.97 |
Interest Expense | -0.09 | -0.07 | -0.3 | -5.36 | -0.42 | -0.04 |
Other Non Operating Income (Expenses) | 0.15 | 0.1 | -0.2 | 1.05 | -0.99 | -0.02 |
EBT Excluding Unusual Items | -11.47 | -7.17 | -7.66 | -10.98 | -4.78 | -3.03 |
Legal Settlements | -0.63 | -0.63 | - | - | - | - |
Other Unusual Items | - | - | -0.58 | -3.65 | - | - |
Pretax Income | -12.1 | -7.8 | -8.24 | -14.63 | -4.78 | -3.03 |
Net Income | -12.1 | -7.8 | -8.24 | -14.63 | -4.78 | -3.03 |
Preferred Dividends & Other Adjustments | 0.77 | 0.81 | 0.21 | - | 0.76 | 0.75 |
Net Income to Common | -12.87 | -8.62 | -8.45 | -14.63 | -5.54 | -3.78 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 12 | 9 | 7 | 3 | 2 | 2 |
Shares Outstanding (Diluted) | 12 | 9 | 7 | 3 | 2 | 2 |
Shares Change | 41.60% | 31.28% | 112.74% | 62.35% | 1.80% | - |
EPS (Basic) | -1.10 | -0.95 | -1.22 | -4.50 | -2.77 | -1.92 |
EPS (Diluted) | -1.10 | -0.95 | -1.22 | -4.50 | -2.77 | -1.92 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -6.47 | -6.46 | -6.13 | -6.72 | -2.3 | -2.24 |
Free Cash Flow Per Share | -0.55 | -0.71 | -0.89 | -2.07 | -1.15 | -1.14 |
Gross Margin | 86.16% | 84.23% | 86.52% | 87.67% | 88.94% | 82.82% |
Operating Margin | -176.51% | -201.70% | -266.46% | -270.91% | -125.61% | -109.14% |
Profit Margin | -197.02% | -241.37% | -314.71% | -594.57% | -206.54% | -138.79% |
Free Cash Flow Margin | -99.10% | -181.10% | -228.08% | -273.36% | -85.65% | -82.16% |
EBITDA | -11.46 | -7.14 | -7.12 | -6.62 | -3.34 | -2.93 |
EBITDA Margin | -175.38% | -200.04% | -265.05% | -269.25% | -124.23% | -107.79% |
D&A For EBITDA | 0.07 | 0.06 | 0.04 | 0.04 | 0.04 | 0.04 |
EBIT | -11.53 | -7.2 | -7.16 | -6.66 | -3.37 | -2.97 |
EBIT Margin | -176.51% | -201.70% | -266.46% | -270.91% | -125.61% | -109.14% |
Advertising Expenses | - | 0.55 | 0.23 | 0.19 | 0.01 | 0.03 |